NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $285,167 | -72.1% | 405,700 | -10.3% | 0.00% | -100.0% |
| Q4 2022 | $1,022,650 | -27.6% | 452,500 | +2.4% | 0.00% | 0.0% |
| Q3 2022 | $1,413,000 | -14.8% | 441,700 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $1,658,000 | -29.5% | 436,400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,352,000 | -56.9% | 436,400 | +7.9% | 0.00% | -66.7% |
| Q4 2021 | $5,463,000 | -24.5% | 404,400 | +0.4% | 0.00% | -40.0% |
| Q3 2021 | $7,234,000 | +6.6% | 402,800 | +1.9% | 0.01% | +25.0% |
| Q2 2021 | $6,785,000 | -17.2% | 395,400 | -3.5% | 0.00% | -20.0% |
| Q1 2021 | $8,196,000 | +19.2% | 409,800 | +1.3% | 0.01% | 0.0% |
| Q4 2020 | $6,877,000 | +2.8% | 404,500 | +0.3% | 0.01% | 0.0% |
| Q3 2020 | $6,692,000 | -26.4% | 403,400 | +2.7% | 0.01% | -37.5% |
| Q2 2020 | $9,095,000 | +49.3% | 392,700 | +15.1% | 0.01% | +33.3% |
| Q1 2020 | $6,090,000 | -16.2% | 341,200 | +1.3% | 0.01% | -14.3% |
| Q4 2019 | $7,270,000 | -30.7% | 336,829 | -41.5% | 0.01% | -36.4% |
| Q3 2019 | $10,485,000 | -47.7% | 575,629 | +2.2% | 0.01% | -50.0% |
| Q2 2019 | $20,046,000 | +3.3% | 563,400 | -2.4% | 0.02% | +4.8% |
| Q1 2019 | $19,404,000 | +5.2% | 577,500 | +2.9% | 0.02% | -12.5% |
| Q4 2018 | $18,440,000 | -44.7% | 561,000 | +2.5% | 0.02% | -35.1% |
| Q3 2018 | $33,357,000 | +28.5% | 547,200 | +2.9% | 0.04% | +23.3% |
| Q2 2018 | $25,963,000 | -11.2% | 531,700 | +93.3% | 0.03% | -16.7% |
| Q1 2018 | $29,222,000 | +83.8% | 275,000 | +3.3% | 0.04% | +111.8% |
| Q4 2017 | $15,903,000 | +155.3% | 266,300 | +2.6% | 0.02% | +142.9% |
| Q3 2017 | $6,228,000 | +24.5% | 259,500 | +1.4% | 0.01% | +16.7% |
| Q2 2017 | $5,001,000 | -15.4% | 255,800 | +1.5% | 0.01% | -14.3% |
| Q1 2017 | $5,912,000 | +95.7% | 251,900 | +2.3% | 0.01% | +40.0% |
| Q4 2016 | $3,021,000 | -20.0% | 246,200 | +12.0% | 0.01% | -16.7% |
| Q3 2016 | $3,778,000 | +19.0% | 219,900 | -1.4% | 0.01% | +20.0% |
| Q2 2016 | $3,175,000 | +7.2% | 223,100 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $2,963,000 | +4.2% | 223,100 | +32.2% | 0.01% | -28.6% |
| Q4 2015 | $2,844,000 | +53.7% | 168,800 | 0.0% | 0.01% | +40.0% |
| Q3 2015 | $1,850,000 | +0.9% | 168,800 | +15.1% | 0.01% | 0.0% |
| Q2 2015 | $1,834,000 | +17.9% | 146,600 | +3.7% | 0.01% | +25.0% |
| Q1 2015 | $1,555,000 | -27.8% | 141,400 | +1.8% | 0.00% | -50.0% |
| Q4 2014 | $2,153,000 | +31.7% | 138,900 | +2.5% | 0.01% | +33.3% |
| Q3 2014 | $1,635,000 | -6.9% | 135,500 | -1.1% | 0.01% | 0.0% |
| Q2 2014 | $1,756,000 | +5.8% | 137,000 | 0.0% | 0.01% | -14.3% |
| Q1 2014 | $1,660,000 | +51.9% | 137,000 | +42.3% | 0.01% | +75.0% |
| Q4 2013 | $1,093,000 | +8.6% | 96,300 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,006,000 | -14.1% | 96,300 | -5.0% | 0.00% | -20.0% |
| Q2 2013 | $1,171,000 | – | 101,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |